TRIM13 (RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activity

  • Moshe E. Gatt
  • , Kohichi Takada
  • , Mala Mani
  • , Mikael Lerner
  • , Marjorie Pick
  • , Teru Hideshima
  • , Daniel E. Carrasco
  • , Alexei Protopopov
  • , Elena Ivanova
  • , Olle Sangfelt
  • , Dan Grandér
  • , Bart Barlogie
  • , John D. Shaughnessy
  • , Kenneth C. Anderson
  • , Daniel R. Carrasco*
    • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'TRIM13 (RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activity'. Together they form a unique fingerprint.

Keyphrases

Immunology and Microbiology

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology